Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
673
-
Total 13F shares, excl. options
-
96,265,199
-
Shares change
-
-473,965
-
Total reported value, excl. options
-
$25,370,506,829
-
Value change
-
-$115,406,017
-
Put/Call ratio
-
90.95%
-
Number of buys
-
304
-
Number of sells
-
-297
-
Price
-
$263.55
Significant Holders of RESMED INC - Common Stock (RMD) as of Q3 2021
744 filings reported holding RMD - RESMED INC - Common Stock as of Q3 2021.
RESMED INC - Common Stock (RMD) has 673 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 96,265,199 shares
of 146,467,184 outstanding shares and own 65.72% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15,557,825 shares), BlackRock Inc. (12,688,574 shares), WCM INVESTMENT MANAGEMENT, LLC (9,087,511 shares), STATE STREET CORP (6,268,561 shares), FMR LLC (4,565,203 shares), Capital World Investors (3,674,333 shares), GEODE CAPITAL MANAGEMENT, LLC (2,945,579 shares), BAILLIE GIFFORD & CO (2,850,142 shares), NORTHERN TRUST CORP (2,258,141 shares), and Invesco Ltd. (1,778,076 shares).
This table shows the top 673 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.